Mcneil Ab

Folke Morén

Kristina Thyresson

Mark Peter Warchol

Elisabeth Sthengel

Sven-Börje Andersson

Kristina Pfizer Health Ab Thyresson

Sven-Börje Pfizer Health Ab Andersson

Elisabeth Pfizer Health Ab Sthengel

Mark P Pfizer Global Research And Dev Warchol

Provided are liquid pharmaceutical formulations comprising nicotine in any form for administration essentially to the lungs being acidified and/or alkalized by buffering and/or pH regulation providing for a tof nicotine in arterial blood of a subject within a short period of time after administration. The administration is preferably accomplished by spraying an aerosol into the oral cavity for further distribution essentially into the lungs. Methods for manufacturing the formulation is also disclosed, as are uses of the formulation in therapy, such as therapy for treating addiction to tobacco.

Formulation and use thereof

A liquid pharmaceutical formulation comprising nicotine in any form for administration essentially to the lungs being acidified and/or alkalized by buffering and/or pH regulation providing for a tof nicotine in arterial blood of a subject within a short period of time after administration. The administration is preferably by spraying an aerosol into the oral cavity for further distribution essentially into the lungs. A method for manufacturing said formulation. Use of said formulation in therapy, such as therapy for treating addiction to tobacco.

Growing community of inventors

Limhamn, Sweden

Folke Morén